Mon.Nov 13, 2023

article thumbnail

Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss

Fierce Pharma

Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. | Novo Nordisk has made a splash with its GLP-1 drugs that have allowed patients to achieve significant weight loss. Now the Danish company appears on the verge of another breakthrough, showing that the use of its obesity treatment Wegovy can reduce the risk of heart attack.

Patients 281
article thumbnail

Report: Workers Trust Employers More Than Insurers With Their Health

MedCity News

Just 37% of employees trust their insurer to suggest high-quality care regardless of cost, while 53% trust their employer with their health, according to a survey released by Included Health.

Insurance 121
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Half a year later, Teva's 'pivot to growth' strategy appears to be bearing fruit

Fierce Pharma

Six months on, Teva’s new “pivot to growth” strategy appears to be paying off. | In 2023’s third quarter, the Israeli-American generics giant reported global sales of $3.9 billion, up 7% from the same period in 2022. The company credited that growth to the strong momentum behind its branded meds Austedo and Ajovy, plus a “stable and sustainable generics business” in the U.S. that’s also seen “continued growth” in Europe and other international markets.

Sales 265
article thumbnail

Novel siRNA therapeutic could lower cardiovascular disease risk

European Pharmaceutical Review

A single dose of lepodisiran, a small interfering RNA ( siRNA ) therapeutic, produced over 94 percent reductions in blood levels of lipoprotein(a), also known as Lp(a), with the results lasting for nearly a year, findings from a Phase I trial show. Lepodisiran Lepodisiran is a siRNA therapeutic that blocks the messenger RNA needed to manufacture a key component of lipoprotein(a) in the liver.

Leads 111
article thumbnail

AI Strategies for Sales Managers: How to Cut Down on Tedious Admin Work

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

article thumbnail

Teva draws $100M from Royalty funding to bankroll long-acting schizophrenia drug

Fierce Pharma

To fuel CEO Richard Francis’s “pivot to growth” plan, Teva has turned to royalty financing to fuel the accelerated development of a pipeline antipsychotic drug in its innovation portfolio. | To fuel CEO Richard Francis’s “pivot to growth” plan, Teva has turned to royalty financing to fuel the accelerated development of a long-acting antipsychotic drug.

144
144
article thumbnail

Could GSK myelofibrosis treatment gain EU-first approval?

European Pharmaceutical Review

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for GSK’s momelotinib, recommending marketing approval. The Committee deemed it beneficial as a treatment for disease-related splenomegaly (enlarged spleen) or symptoms in adults with moderate to severe anaemia who have primary myelofibrosis, post polycythaemia vera myelofibrosis or post essential thrombocythaemia myelofibrosis and who are Janus kinase (JAK) inhibitor n

Medicine 109

More Trending

article thumbnail

FDA grants orphan drug designation to MAIA’s glioblastoma agent  

Pharmaceutical Technology

As per the company, the candidate THIO, is the only direct telomere-targeting agent currently in clinical development.

FDA 111
article thumbnail

Healthcare Doesn’t Need More Big Tech; It Needs Specialized Tech

MedCity News

It’s easy to oversimplify and say, “These big tech companies are now doing healthcare and they’re going to solve everything.” But the reality is that often, the solutions are not going to come from big tech.

article thumbnail

Humans can’t shake the mosquito threat. Here’s what pharma has in the pipeline.

PharmaVoice

The arsenal against the world’s deadliest creature is growing and a universal vaccine is in the works.

Pharma 116
article thumbnail

Loneliness and its Impact on Alzheimer’s Patients: Harnessing Companion Animal Digital Technology

MedCity News

A significant healthcare crisis looms as Baby Boomers age, which will contribute to a rise in Alzheimer’s cases. Combined with a shortage of geriatricians and caregivers, we will soon have more lonely seniors in America. We must open our minds to new solutions, such as robotic companions.

Patients 111
article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Medical Debts in America: Collections, Aggressive Tactics, and Consequences

PharmExec

The growing issue of medical debt has caused stakeholders to reevaluate tactics as the cost of pharmaceutical healthcare continues to rise.

Medical 98
article thumbnail

Novartis to Pay Legend Biotech $100M in Pact Bringing Cell Therapy to Solid Tumors

MedCity News

Novartis gains global rights to Legend Biotech cell therapies that address DLL3, a promising target for lung cancers and other types of solid tumors. The pharmaceutical giant may make these therapies using T-Charge, its next-generation CAR T-cell therapy manufacturing technology.

article thumbnail

UK announces $326.4m funding to improve drug and alcohol treatment

Pharmaceutical Technology

The UK government has announced £267m ($326.4m) funds for developing treatments for drug and alcohol misuse.

article thumbnail

Ajinomoto Adds Gene Therapy to CDMO Scope via $554M Forge Bio Buyout

MedCity News

Ajinomoto’s Forge Biologics acquisition brings contract development and manufacturing organization capabilities in gene therapy. Forge specializes in manufacturing AAV vectors used to deliver these therapies.

article thumbnail

How to Prove Marketing Value: Demonstrate Content ROI and Contribution to Sales

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

article thumbnail

BIO-Europe 2023: Barriers remain in the AI pharma revolution

Pharmaceutical Technology

At the BIO-Europe conference, experts discussed remaining challenges in AI healthcare interventions.

Pharma 98
article thumbnail

Psychiatry’s Future Progress Depends on Innovation, Collaboration, and Access

MedCity News

We are on the edge of rapid innovation in psychiatry. Now is the time to break out of our silos and take advantage of the promise the future holds.

FDA 113
article thumbnail

Victoria Atkins replaces Barclay as UK health secretary

pharmaphorum

Victoria Atkins replaces Barclay as UK health secretary Phil.

118
118
article thumbnail

OmniLife Health’s Clinical Workflow Solution Focuses on Complex Care [Sponsored]

MedCity News

OmniLife Health’s initial focus with its complex care coordination platform is organ transplant care.

article thumbnail

Optimizing Clinical Supply Strategy: Navigating Challenges & Finding Your Ideal Model

article thumbnail

Digital Hollywood Focus on AI and Copyright

Copyright Clearance Center

The post Digital Hollywood Focus on AI and Copyright appeared first on Copyright Clearance Center.

96
article thumbnail

Equity for Women in Healthcare: 131 Years is Too Long to Wait

PharmExec

Closing the gender gap in pharma—and how we get there together.

article thumbnail

Welcome New Board Member: Jeanne Miller

MedTechVets

NOV 14th – We were proud to interview and welcome new MedTechVets Board Member, Jeanne Miller. She is the Area Vice President of Sales for Biosense Webster , a division of Johnson & Johnson MedTech and a proud wife and mother of four. Jeanne began her service in the U.S. Marine Corps as an Aviation Supply Officer after graduating from the United States Naval Academy.

Medical 64
article thumbnail

Sandoz opens new antibiotic and biosimilar facilities in Austria and Germany

PharmaTimes

Antimicrobial resistance is considered one of the top ten global public health threats - News - PharmaTimes

83
article thumbnail

Increase Revenue With Better, Faster Sales Onboarding

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

article thumbnail

UCB on course for approval of gMG drug Rystiggo in EU

pharmaphorum

UCB on course for approval of gMG drug Rystiggo in EU Phil.

106
106
article thumbnail

IO Biotech enrols 380 patients with advanced melanoma in phase 3 trial

PharmaTimes

The trial is evaluating an investigational cancer vaccine in combination with Keytruda - News - PharmaTimes

article thumbnail

Akili says OTC switch for ADHD DTx leads to sales rise

pharmaphorum

Akili says OTC switch for ADHD DTx leads to sales rise Phil.

Leads 103
article thumbnail

e-Data and the Biopharmaceutical Supply Chain

PharmExec

MilliporeSigma’s Stephen Wing, head of Analytical and Logistical Services, discusses the ways in which digital transformation and data transparency dramatically enhance supply chains, and how manufacturers are using the company’s eMERGE™ platform to improve overall efficiencies.

article thumbnail

European Clinical Supply Planning: Balancing Cost, Flexibility and Time

article thumbnail

CHMP backs GSK’s momelotinib for myelofibrosis

pharmaphorum

CHMP backs GSK’s momelotinib for myelofibrosis Phil.

102
102
article thumbnail

Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain

PharmaTech

In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.

Pharma 52
article thumbnail

Are Prescribers More Likely to Change Behavioral Segment or Product Loyalty?

The Marketing Advantage

November 13, 2023 Two critical elements that inform how biopharma sales representatives sell to HCPs are (1) the prescribing behavior exhibited by the HCP, or behavioral segment , and (2) the HCP’s loyalty to the products they prescribe. However, over the years, we have found that a prescriber’s loyalty to one of these two elements is stronger than the other, which, accordingly, has significant implications for how biopharma sales forces should sell to prescribers.

article thumbnail

FDA Approves Expanded Nerve Block Indications for Pacira BioSciences' Exparel

PharmExec

FDA expands indications for bupivacaine liposome injectable suspension (Exparel; Pacira BioSciences, Inc.) for use in adult patients as an adductor canal block and a sciatic nerve block in the popliteal fossa.

FDA 40
article thumbnail

Using Generative AI in Sales: Pros, Cons, and Considerations According to Sellers

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A